More From Peripheral Artery Disease (PAD)

In this article, three unique clinical scenarios are presented in which endovascular therapy prevented major amputations and improved patient outcomes.
Dr. Gary Ansel explains the importance of choosing the right treatment algorithm for SFA disease in the COVID-19 environment and provides an overview of the complimentary one-hour CME-accredited course.
Paul Michael, MD, and Richard Neville, MD, discuss how to work across disciplines to help improve outcomes for patients with CLI.
Presented at ISET 2020 by Bret N. Wiechmann, MD, FSIR, FAHA, FSVM.
Presented at ISET 2020 by Fadi A. Saab, MD, FACC, FSCAI, FASE. TAMI stands for Tibiopedal Arterial Minimally Invasive retrograde revascularization.
With the evolution of endovascular techniques, historically untreated patients now have options. The tibio-pedal artery minimally invasive (TAMI) approach is safe and feasible when patients are at risk of transfemoral access complications.
Hear from George L. Adams, MD, MHS, MBA, FACC, FSCAI, in his presentation at the International Symposium on Endovascular Therapy (ISET) 2020 meeting.
Shammas and colleagues discuss how treatment of infrapopliteal arteries can be challenging due to the presence of medial calcinosis and fibrotic rings.
“We have seen a proliferation of wound care centers, but still felt there was a lack specifically for the patients with diabetic wounds and critical limb ischemia.”
Featuring Mehdi H. Shishehbor, DO, PhD, MPH, Director, Interventional Cardiovascular Center, Co-Director, Vascular Center, Harrington Heart and Vascular Institute, University Hospitals, Cleveland, Ohio.